EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSHHUG00000024201
Gene Symbol: DHCR24
1 Cross references
202 Possible Orthologues:

24-Dehydrocholesterol Reductase

Ensembl ID : ENSHHUG00000029475
Gene Symbol: DHCR24
1 Cross references
202 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSHHUG00000052899
Gene Symbol: HMGCR
1 Cross references
194 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase B

Ensembl ID : ENSHHUG00000012474
Gene Symbol: HMGCRB
1 Cross references
205 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1a

Ensembl ID : ENSHHUG00000029770
Gene Symbol: PDPK1A
1 Cross references
169 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1a

Ensembl ID : ENSHHUG00000051118
Gene Symbol: PDPK1A
1 Cross references
169 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1b

Ensembl ID : ENSHHUG00000006500
Gene Symbol: PDPK1B
1 Cross references
215 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1b

Ensembl ID : ENSHHUG00000042909
Gene Symbol: PDPK1B
1 Cross references
214 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase B

Ensembl ID : ENSHHUG00000020679
Gene Symbol: HPDB
2 Cross references
198 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase B

Ensembl ID : ENSHHUG00000003886
Gene Symbol: HPDB
1 Cross references
198 Possible Orthologues:

5'-Nucleotidase, Ecto (Cd73)

Ensembl ID : ENSHHUG00000019190
Gene Symbol: NT5E
1 Cross references
178 Possible Orthologues:

5'-Nucleotidase, Ecto (Cd73)

Ensembl ID : ENSHHUG00000025743
Gene Symbol: NT5E
1 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).